Table 2 Coexisting diseases vs. life satisfaction in young adults with T1DM.

From: Satisfaction with life in young adults with type 1 diabetes mellitus

Coexisting diseases

N (%)

Satisfaction with life-raw score mean ± SD/median (Q1, Q3)

Satisfaction with life-standard ten mean ± SD/median (Q1, Q3)

HbA1c level (%)

222 (100%)

7.65 (6.80, 8.70)

Hypertension

Yes

26 (11.7%)

19.0 (14.0, 24.0)

5.00 (3.00, 7.00)

No

196 (88.3%)

20.0 (15.5, 24.0)

5.00 (4.00, 7.00)

p

0.54*

0.59*

Hypothyroidism

Yes

71 (32%)

18 ± 5.7

4.69 ± 1.95

No

151 (68%)

20.8 ± 6.3

5.65 ± 2.25

p

0.002** (post hoc power = 91.0%)

0.002** (post hoc power = 90.2%)

Hyperthyroidism

Yes

11 (5%)

16.0 (12.0, 22.0)

4.00 (3.00, 6.00)

No

211 (95%)

20.0 (16.0, 25.0)

5.00 (4.00, 7.00)

p

0.04*

0.02*

Coeliac disease

Yes

16 (7.2%)

15.0 (12.5, 20.0)

3.50 (3.00, 5.00)

No

206 (92.8%)

20.0 (16.0, 25.0)

5.00 (4.00, 7.00)

p

0.006* (post hoc power = 83.5%)

0.004* (post hoc power = 87.8%)

asthma

Yes

7 (3.2%)

No

214 (96.8%)

p

Rheumatoid arthritis

Yes

5 (2.3%)

No

217 (97.7%)

p

 

Atherosclerosis

Yes

3 (1.4%)

No

219 (98.6%)

p

Diabetic nephropathy

Yes

5 (2.3%)

No

217 (97.7%)

p

Diabetic retinopathy

Yes

10 (4.5%)

16.5 (9.0, 24.0)

4.00 (1.00, 7.00)

No

212 (95.5%)

20.0 (16.0, 24.0)

5.00 (4.00, 7.00)

p

0.13*

0.16*

Diabetic neuropathy

Yes

12 (5.4%)

20.0 (11.5, 22.5)

5.50 (2.00, 6.50)

No

210 (94.6%)

20.0 (15.0, 24.0)

5.00 (4.00, 7.00)

p

0.33*

0.38*

Lipohypertrophy

Yes

44 (19.8%)

19 ± 7

5 ± 2.4

No

178 (80.2%)

20.1 ± 6

5.43 ± 2.15

p

0.27**

0.25**

Lipoatrophy

Yes

5 (2.3%)

No

217 (97.7%)

p

-

  1. *Mann–Whitney U test; **ANOVA; ***Kruskal‒Wallis test; T1DM Type 1 diabetes mellitus, N numer, SD standard deviation, Q1–Q25 25th lower quartile, Q3–Q75 75th upper quartile interquartile range.